TY - JOUR T1 - Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment JF - Anticancer Research JO - Anticancer Res SP - 5975 LP - 5981 VL - 37 IS - 11 AU - BENJAMIN N. HO AU - CLAIRE M. PFEFFER AU - AMARESHWAR T.K. SINGH Y1 - 2017/11/01 UR - http://ar.iiarjournals.org/content/37/11/5975.abstract N2 - The emerging field of nanotechnology meets the demands for innovative approaches in the diagnosis and treatment of cancer. The nanoparticles are biocompatible and biodegradable and are made of a core, a particle that acts as a carrier, and one or more functional groups on the core which target specific sites. Nanotech in drug delivery includes nanodisks, High Density Lipoprotein nanostructures, liposomes, and gold nanoparticles. The fundamental advantages of nanoparticles are: improved delivery of water-insoluble drugs, targeted delivery, co-delivery of two or more drugs for combination therapy, and visualization of the drug delivery site by combining imaging system and a therapeutic drug. One of the potential applications of nanotechnology is in the treatment of cancer. Conventional methods for cancer treatments have included chemotherapy, surgery, or radiation. Early recognition and treatment of cancer with these approaches is still challenging. Innovative technologies are needed to overcome multidrug resistance, and increase drug localization and efficacy. Application of nanotechnology to cancer biology has brought in a new hope for developing treatment strategies on cancer. In this study, we present a review on the recent advances in nanotechnology-based approaches in cancer treatment. ER -